COVID-19 vaccination in patients with immunity-mediated kidney disease.

Prendecki, Maria; Willicombe, Michelle; McAdoo, Stephen P

Prendecki, Maria; Willicombe, Michelle; McAdoo, Stephen P.

Prendecki M; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK. m.prendecki@imperial.ac.uk.
Willicombe M; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK. m.prendecki@imperial.ac.uk.
McAdoo SP; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK. m.willicombe08@imperial.ac.uk.

Nat Rev Nephrol ; 17(12): 790-791, 2021 12.

Article in English | MEDLINE | ID: covidwho-1475305

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19; Kidney Diseases; COVID-19/prevention & control; Humans; Kidney Diseases/immunology; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Kidney Diseases Topics: Vaccines Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2021 Document Type: Article Affiliation country: S41581-021-00502-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google